Synergetic B-Cell Immunomodulation With Rituximab and Belimumab Is Clinically Effective in Severe and Refractory Systemic Lupus Erythematosus - The Synbiose Proof-of-Concept Study
Journal article published in 2017 by
Tineke Kraaij,
Sylvia Kamerling,
Esther de Rooij,
Paul van Daele,
Ingeborg Bajema,
Obbo Bredewold,
Tom Huizinga,
Ton Rabelink,
Cees van Kooten,
Y. K. Onno Teng 
